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Abstract
Over the last decade, the Dutch mental healthcare system has been subject to profound policy reforms, in order to achieve 
affordable, accessible, and high quality care. One of the adjustments was to substitute part of the specialized care for general 
mental healthcare. Using a quasi-experimental design, we compared the cost-effectiveness of patients in the new setting with 
comparable patients from specialized mental healthcare in the old setting. Results showed that for this group of patients the 
average cost of treatment was significantly reduced by, on average, €2132 (p < 0.001), with similar health outcomes as in 
the old system.
Keywords Cost-effectiveness · Depression · Anxiety
Background
Over the last decade, significant changes have been imple-
mented in the organization and financing of the mental 
healthcare system in the Netherlands (Nas and Van Geldr-
dop 2013; Westra et al. 2016). The reforms started with the 
introduction of regulated competition, in which service pro-
viders have to negotiate with health insurers on both costs 
and quality of care. The overall goal of the reforms was to 
realise a national healthcare system that is accessible for 
every citizen, is affordable, and improves the quality of care.
One of the reforms was de introduction of the so-called 
basic mental healthcare segment, targeting those patients 
with a mental disorder who could be helped with relatively 
short term generic interventions, rather than with the more 
specialized treatments in the specialized mental health-
care segment. The defining feature of the new basic mental 
healthcare segment was that it introduced short treatment 
products, limited to roughly five, eight, or twelve sessions. 
This, in contrast to specialized mental healthcare, where 
treatments can be as short as five sessions, but are not lim-
ited in duration. The General Practitioner (GP) serves as 
a gatekeeper to both segments, referring patients to either 
basic mental healthcare or specialized mental healthcare. 
This means that it is not possible for patients to transfer 
freely between the segments. Other than that, the organiza-
tion and financing structure of both segments are compara-
ble, with for example treatments requiring co-payments from 
patients in both segments.
Basic mental healthcare was intended to serve a subset of 
patients who would previously have been treated in special-
ized mental healthcare. This subset includes patients with 
mild to severe mental health problems and with low to mod-
erate complexity, and with low risk of suicide or dangerous 
behaviour. Due to the limited treatment duration in basic 
mental healthcare, it is likely (but not necessarily the case) 
that the cost per patient is lower in basic mental healthcare. 
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However, it is not known whether restricting the treatment 
duration comes with a loss of effectiveness.
This study is a cost-effectiveness analysis of basic health-
care in comparison with specialized mental healthcare, in 
which equivalent patients from before and after the introduc-
tion of basic mental healthcare are compared.
Methods
Setting
In this study we used routine administrative data (from a 
nationwide franchised company) from a two year period 
after the introduction of basic mental healthcare, as well 
as data (from two large specialized mental healthcare agen-
cies) from a 3 year period before the introduction of basic 
mental healthcare. The two large specialized mental health-
care agencies have multiple sites in both urban and rural 
areas. The patient population consists of people of all ages 
and psychiatric disorders, and the agencies offer a broad 
range of specialized inpatient and outpatient treatment. The 
nationwide franchised company consists of 200 locations 
scattered over a large part of the Netherlands, also in both 
urban and rural areas. The company offers only outpatient 
basic mental healthcare products for patients with all kinds 
of disorders. Depression and anxiety disorders are the most 
common disorders in basic mental healthcare.
Design
Because this study was performed in a naturalistic setting, 
the most rigorous design that could be used was a historical 
matched cohort study. The study used real data, which was 
generated and stored during the execution of treatment, and 
was used for reimbursement. Pre- and post-treatment test 
scores were used to analyse treatment effects, and reimburse-
ment data was used to determine costs. Costs and effects 
over the restricted treatment duration in the basic mental 
healthcare setting were compared with costs and effects in 
the treatment period in the specialized mental healthcare 
setting.
Patient Cohorts
The first sample included patients from specialized men-
tal healthcare whose treatment started in the years 2011, 
2012, or 2013. The second sample included patients from 
basic mental healthcare whose treatment started in 2014 or 
2015. To increase comparability between the samples, only 
patients were included who:
• received outpatient care for a main diagnosis of depres-
sion or anxiety disorder,
• had not received earlier treatment for their mental disor-
der in that mental healthcare setting (first treatment),
• had valid ROM test scores at the start and at the end of 
treatment,
• were not defined as chronically ill.
In order to deal with overt selection bias, a propensity 
score matching algorithm was used to select patients from 
both samples (Austin 2011a). Adjustment for remaining 
confounding differences was done by using a regression 
analysis to assess the differences in cost and effect. Findings 
are reported in line with the Consolidated Health Economic 
Evaluation Reporting Standards (CHEERS) (Husereau et al. 
2013).
Data Collection
Data was collected for the period from 2011 until 2013 
from the two large mental healthcare agencies, and for the 
period from 2014 until 2016 from the franchised company. 
The registration data included all activities performed dur-
ing the treatment from diagnostic intake to discharge. This 
data exactly described the amount of time that each type 
of healthcare professional was involved. Routine Outcome 
Monitoring (ROM) data was collected to determine the pri-
mary clinical outcome of a treatment. Only patients with no 
missing data were included in the analysis.
Health Outcome
The primary clinical outcome was defined as the standard-
ized improvement in level of symptom severity between 
the start and the end of a treatment. Symptom severity was 
measured with a ROM questionnaire at several evaluation 
moments in the treatment. In the participating mental health-
care agencies and the franchised company, different instru-
ments were used to measure symptom severity. Therefore, 
the difference in test score was converted to a Cohen’s d 
effect size (Cohen 1988). The ROM instruments used in 
our analyses were the symptom-distress scale of the Out-
come Questionnaire (OQ-45.2) and the short symptom list 
(KKL, Korte Klachten Lijst) (Lambert et al. 2004; Lange 
and Appelo 2007).
Instruments
The KKL is a self-report questionnaire that measures the 
degree of suffering from common mental health problems 
such as anxiety, depression, eating disorders, sleeping prob-
lems, and addiction (van de Ven et al. 2000). The 13 items 
of the questionnaire are scored on a 5-point Likert scale, 
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ranging from 0 (not suffering at all) to 4 (a vast amount of 
suffering). Psychometric properties of the KKL were accept-
able to good (Lange and Appelo 2007; van de Ven et al. 
2000).
The OQ-45.2 is a standardized self-report outcome meas-
ure designed for repeated measurement of client progress in 
therapy, and assesses problems relating to anxiety, depres-
sion, and substance abuse (Lambert et al. 2004). The 25 
items of the Symptom Distress (SD) subscale of the OQ-45.2 
are scored on a 5-point Likert scale, ranging from 0 (never) 
to 4 (almost always). Psychometric properties of the Dutch 
OQ-45.2 were adequate (De Jong et al. 2007).
Costs
The costs of each treatment were calculated from a health-
care perspective and included staff costs, overhead, and 
employer’s contribution, in accordance with the Dutch 
Guideline on economic evaluations in healthcare (Hak-
kaart-van Roijen et al. 2015). The costs of treatment were 
estimated using volume × cost per unit, where volume is 
equal to the hours of involvement of each type of healthcare 
professional, and cost per unit is the gross annual salary of 
each type of healthcare professional divided by 1300 bill-
able hours. In accordance with the guideline, we took the 
median gross annual salary scale of each type of medical 
staff from the collective agreements of Dutch mental health 
services of 2015. The same salary scale was used for both 
samples and we did not adjust for inflation. According to the 
guidelines, an increment of 35% on the costs for employer’s 
contribution was used, and another increment of 38% for the 
overhead costs. Table 1 presents the unit cost for each type 
of healthcare professional in the dataset.
Cost‑Effectiveness Analysis
The cost-effectiveness results are presented as an incremen-
tal cost-effectiveness ratio (ICER). The ICER describes the 
incremental costs for one additional health effect gained in 
basic mental healthcare treatment as compared to special-
ized mental healthcare treatment (Husereau et al. 2013). 
One additional health effect gained is defined as standard-
ized improvement in level of symptom severity (expressed 
in effect size d) measured with the ROM-instruments as 
described under Health Outcome.
Statistical Analyses
All of our statistical analyses were performed in R, an open 
source statistical programming environment (R Core Team 
2016). A propensity score matching algorithm from the R 
package ‘matching’ was used to balance the distribution 
of five known covariates: gender, age, baseline symptom 
severity, diagnosis group, and country of origin (Austin 
2011a; Sekhon 2011). Because symptom severity was meas-
ured with different instruments, baseline symptom severity 
score was converted to a Z-score. Country of origin was 
clustered into three categories: the Netherlands, abroad (not 
born in the Netherlands), and unknown.
In order to balance statistical power and group homoge-
neity, an optimal 1:1 nearest-neighbour matching algorithm 
without replacement was used, with a calliper of maximally 
0.1 standard deviation on each of the covariates (Austin 
2011b). In line with the guidelines reported by Baser (Baser 
2006), five criteria were analysed to diagnose the balance 
properties of the matched sets. First, the continuous vari-
ables, age and baseline severity, were compared with a t 
test; and the categorical variables, gender, diagnosis group, 
and country of origin, were compared with a Chi square 
test. Second, standardized mean differences were calcu-
lated. Samples with a standardized mean difference of less 
than 0.1 on each covariate indicated negligible differences 
(Normand et al. 2001). Third, the percentage of reduction 
bias in the means was calculated for the variables, age and 
baseline severity. Fourth, a Kolmogorov–Smirnov test was 
used to compare the density estimates for the covariates, 
age and baseline severity (Conover 1999). Fifth, a Kolmog-
orov–Smirnov test was used to compare the density esti-
mates of the produced propensity scores of the two matched 
samples.
Multiple linear regression was used to calculate the dif-
ferences in cost and outcome between the two samples, with 
age, gender, baseline symptom severity, diagnosis group, 
and country of origin as covariates. The differences were 
expressed using the ICER.
The impact of the uncertainty of the regression coef-
ficients on the ICER was assessed with a non-parametric 
Table 1  Unit cost overview
The unit cost is the median salary of each type of healthcare profes-
sional according to the collective agreement of Dutch mental health-
care 2015, with an increment of 35% employer’s contribution and 
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bootstrap analysis of the package ‘boot’ (Davison and Hin-
kley 1997; Ripley and Canty 2016). This analysis samples 
a subset of the data 2500 times, and the differences in cost 
and outcome of different subsets of the population were 
estimated with a regression analysis. The bootstrapped out-
comes of the ICER were presented in a cost-effectiveness 
plane and cost-effectiveness acceptability curve (van Hout 
et al. 1994).
Sensitivity Analysis
Three assumptions were made to determine the cost per 
unit for each type of healthcare professional in both mental 
healthcare systems. These assumptions concern caregiver 
salary, number of billable hours, and overhead costs. The 
uncertainties in these assumptions were analysed by hypo-
thetically varying the parameters to the disadvantage of 
basic mental healthcare. First, we increased the salaries of 
medical staff in basic mental healthcare by 10%. Then, we 
reduced the number of billable hours from 1300 to 1100. 
Finally, we increased the increment for overhead costs to 
50% instead of 38%.
No assumptions were made in the estimation of treatment 
effect, and only empirical data was used to compare the out-
come between the two mental healthcare systems.
Results
Sample Characteristics
A dataset of 11,867 patients with no missing information 
was available for the matching algorithm, which is about 
50% of the total patient population of each organization that 
met the inclusion criteria.
Table 2 presents the characteristics of the two samples, 
of 4343 patients each, created by the matching algorithm. 
Four of the five criteria for a balanced set are met. First, 
the p values of each covariate indicate no significant dif-
ferences between the means and distributions. Second, the 
standardized mean differences are below the threshold value 
of 0.1. Third, the calculated percentage in reduction bias in 
means of baseline severity (99.4) and age (93.1) are near 100 
percent. Fourth, there is no significant difference between 
the density estimates of the produced propensity scores in 
the two matched samples [KS, D(4343) = 0.131, p = 0.849]. 
However, there is a significant difference between the den-
sity estimates of the covariates, age [KS, D(4343) = 0.044, 
p < 2.22e−16] and baseline severity [KS, D(4343) = 0.063, 
p < 2.22e−16].
Table 3 presents the percentage of the treatment time pro-
vided by each type of healthcare professional in specialized 
and in basic mental healthcare, the resulting average treat-
ment cost, and the average treatment effect, without adjust-
ment for remaining confounding differences. The average 
unit cost for specialized mental healthcare is €75 and for 
basic mental healthcare is €83. The average number of treat-
ment hours is 39.4 in specialized mental healthcare and 9.8 
in basic mental healthcare.
Cost‑Effectiveness Analysis
Table 4 presents the outcome of the regression analysis and 
the incremental cost-effectiveness ratio. The table shows that 
treatment in basic mental healthcare occurs at significantly 
lower cost than treatment in specialized healthcare (− €2132; 
p < 2e− 16). Incremental health outcomes (expressed as effect 
size d) amount to 0.007. This difference in effect is not sig-
nificant (p = 0.724) and not clinically relevant. With reduced 
costs and similar health outcomes, on average, the new 
healthcare system is dominant in terms of cost-effectiveness.
Table 2  Sample size and 
observed patient characteristics 
after propensity score matching
Baseline severity is expressed as a Z-score; country of origin ‘Abroad’ was defined as not born in the Neth-
erlands




Basic mental healthcare SMD p value
N 4343 4343
Gender = F (%) 2762 (63.6) 2764 (63.6) 0.001 0.982
Age [mean (SD)] 38.0 (12) 38.1 (13.2) 0.009 0.682
Baseline severity [mean (SD)] 0.07 (0.98) 0.07 (0.92) 0.001 0.956
Diagnosis group = depression disorder (%) 2135 (49.2) 2183 (50.3) 0.022 0.313
Country of origin (%) 0.014 0.817
 Netherlands 3444 (79.3) 3422 (78.8)
 Abroad 715 (16.5) 737 (17.0)
 Unknown 184 (4.2) 184 (4.2)
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Uncertainty Analysis
The impact on the ICER of uncertainty in our coefficients 
is shown in the cost-effectiveness plane (Fig. 1). The cost-
effectiveness plane shows the outcome of the bootstrap 
analysis. The distribution of bootstrapped ICERs shows 
that 62% of the outcomes fall in the lower right-hand quad-
rant, which implies that the new system has a better health 
outcome at lower cost. For 38%, the ratio falls in the lower 
left-hand quadrant, which indicates that the new system has 
a worse health outcome at lower cost, though the maximum 
loss of effect is d = 0.06, which can be considered very small 
(Cohen 1988).
Sensitivity Analysis
The average costs were calculated with a change in three dif-
ferent input parameters to the disadvantage of basic mental 
healthcare. Increasing the salary of basic mental healthcare 
professionals by 10%, reducing the number of billable hours 
in basic mental healthcare to 1100, or increasing the incre-
ment in overhead costs to 50%, does not change the conclu-
sion of the analysis. The variation in billable hours has the 
most impact, and increases the average cost of basic mental 
Table 3  Discipline mix of 
healthcare professionals, 
mean treatment cost, and 
mean treatment effect (after 
propensity score matching)







Clinical psychologist 2% 1%
Social worker 5% 0%




Psychiatric nurse 9% 0%
Mental health psychologist 14% 70%
Basic psychologist 34% 0%
Unknown 0% 24%
Other 8% 0%
Cost [€ (SD)] 2952 (2788) 816 (362) 1.074 < 2.2e−16
Health outcome [d (SD)] 0.89 (1.02) 0.90 (1.02) 0.007 0.758
Table 4  Cost-effectiveness 
predicted with regression 
analysis
ICER incremental cost effectiveness ratio
Basic mental healthcare compared to 
specialized mental healthcare
Std Error t value p value
Additional cost − €2132 42.328 − 50.373 < 2.0e− 16
Additional effect 0.007 0.021 0.352 0.725
ICER Dominant
Fig. 1  Cost-effectiveness plane for basic mental healthcare compared 
to specialized mental healthcare. Cost-effectiveness plane, presenting 
the 2500 bootstrap iterations in which the incremental cost-effective-
ness ratio is estimated using a regression analysis. Effect in effect size 
D; costs are in euros
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healthcare to €963, which would reduce the difference in 
costs from €2133 to €1986.
Discussion
In the short run, it seems that the treatment setting in 
basic mental healthcare contributed towards the aims of 
the healthcare reform, i.e. lower costs with equal or better 
outcome. This means that for a specific population, short-
ening treatment duration does not come at the expense of 
the effectiveness of the treatment. This is in line with the 
outcomes presented by Cuijpers et al. (Cuijpers et al. 2013), 
who used a meta regression analysis to show that there was 
no association between the number of therapy sessions and 
the effect size when using psychotherapy in the treatment of 
adults with depression. Finding similar effectiveness in these 
short treatments in basic mental healthcare may be due to the 
prior knowledge of both therapist and patient that treatment 
will be of limited duration. This knowledge may influence 
the behaviour of the patient as well as the therapist. Several 
studies show that the actual number of sessions is related to 
the number of sessions expected by patients (Mueller and 
Pekarik 2000; Owen et al. 2009). Moreover, the expectation 
of a short treatment compared to the expectation of a long 
treatment is related to a quicker response (Barkham et al. 
1996). For a therapist, this limitation means that on the one 
hand the treatment has to be focused from the very start but 
on the other hand the therapist must actively encourage the 
self management and empowerment of the patient. Focus-
ing, i.e. minimizing distractions and changes in treatment, 
increases the effectiveness of treatment (Schulte and Eifert 
2002). This requires therapists who are specifically trained 
in such a focussed method, and who are able to empower 
the patient to take responsibility and self direction in his 
treatment.
It is interesting to note that, in our dataset, the average 
cost per hour in basic mental healthcare is actually higher 
(€83) than the average cost per hour in specialized mental 
healthcare (€75). Basic mental healthcare professionals are 
very well educated, but specialized mental healthcare pro-
fessionals have a higher and more specialized education. 
However, basic mental healthcare is primarily monodisci-
plinary, i.e. healthcare professionals generally work alone, 
whereas specialized mental healthcare is multidisciplinary 
and includes a large proportion of staff with a lower level of 
education. The composition of the multidisciplinary teams 
in specialized mental healthcare corresponds with a lower 
average cost per hour than the monodisciplinary counterpart 
in basic mental healthcare.
Given the short duration considered in this analysis, the 
results are promising and potentially of high relevance to 
policymaking. Providing a duration-limited treatment to 
patients with anxiety or depression has the potential to 
decrease budget without losing health effects. The number 
of patients qualifying for such treatment is high, with an 
estimated 260,000 patients per year being treated (KPMG 
2016) in basic mental healthcare in the Netherlands, and 
with an estimated 125,000 patients per year being treated 
for anxiety or depression, who were formerly being treated 
in specialized mental healthcare. Our preliminary results 
therefore suggest that this entails a savings potential of about 
270 million euros per year in the Netherlands. As the transi-
tion was still in progress in the time period considered in 
this report, it is important to monitor the patient population 
treated in basic mental healthcare, such that future research 
can evaluate to what extent our sample is representative 
for patients treated in basic mental healthcare. All in all, 
the promising results in our analysis, and the magnitude of 
potential savings at a national level, justify giving priority 
to further research in this area. Furthermore, our approach 
could be used in more and broader settings, for instance to 
evaluate differences in healthcare between different regions 
or countries, thereby emphasizing best practice that could 
be used to further improve healthcare (de Beurs et al. 2015).
Future research is needed to further evaluate the system 
change. The analysis presented in this article provides a 
starting point for using administrative data to monitor the 
cost-effectiveness of such a system change. With more data 
available it would be possible to analyse potential relapse 
effects and to investigate whether the treatment effect of 
basic mental healthcare persists in the long run. On top of 
that, more data could be gathered about additional costs and 
benefits not directly related to mental healthcare treatment. 
With such data it is possible to analyse whether the new 
system is still cost-effective using a broader perspective. A 
randomized controlled trial similar to the study of Barkham 
et al. (Barkham et al. 1996) might not reveal the full impact 
of shortening treatment and changing the focus and respon-
sibilities of treatment in a new setting. Therefore a cluster 
randomized controlled trial or a stepped wedge study should 
be used to confirm whether knowing at the time of starting 
treatment that its duration will be limited, results in lower 
costs with equal effects.
Limitations
The main strength of our approach is the use of a large data-
base of routine outcome monitoring data that allowed us 
to conduct a real-life experiment with historical matched 
cohorts from before and after a system change. Our study 
has a number of limitations, however, that need to be 
acknowledged.
First, as patients were not randomized, and only patients 
with no missing data were included, there is a risk of both 
overt and hidden selection bias. To minimize the risk of 
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overt selection bias, patients in both groups were matched 
using the propensity score algorithm as outlined by Austin 
et al. (Austin 2011b). Additional checks on the quality of 
the resulting matched samples as recommended by Baser 
(Baser 2006) revealed that four of the five criteria were 
fulfilled. The criterion that was not fulfilled was the Kol-
mogorov–Smirnov test on the individual covariates, age and 
baseline severity, which is used to test whether these covari-
ates in both samples, after matching, are drawn from the 
same distribution. Additionally, the Mann–Whitney test was 
used to test for similar distributions, showing that the two 
samples produced by the propensity score algorithm were 
likely to follow a similar distribution of the covariates, age 
[MW(4343), p = 0.327] and baseline severity [MW(4343), 
p = 0.432]. Moreover, one of the criteria that was fulfilled 
entailed a Kolmogorov–Smirnov test to indicate that both 
samples follow a similar distribution of the produced pro-
pensity score, which can be seen as a summary of the dis-
tribution of all covariates together (Austin 2011a). Further-
more, a regression analysis was used to adjust for remaining 
confounding differences. However, no technique [such as an 
instrumental variable approach (De Ridder and De Graeve 
2011)] was used to deal with hidden selection bias.
Second, we compared the difference in cost and effect 
only over the duration of a completed treatment and not over 
a set period of time. Because the difference in cost is due to 
the difference in duration between the treatments in the two 
systems, it is possible that both cost and treatment effects are 
biased. We are unaware of how the treatment effects, occur-
ring in the basic mental healthcare sample, persist after the 
end of these short treatments. Furthermore, we do not know 
how much care the patients in basic mental healthcare have 
consumed alongside and after their treatment. What we do 
know is that only about 5% of the patients in basic mental 
healthcare are referred to specialised mental healthcare after 
treatment termination (KPMG 2016).
Third, our analysis is limited to patients treated for anxi-
ety and/or depression. It is unclear what the cost-effective-
ness of the health system change is for patients treated for 
different disorders. Patients with anxiety and depression are 
estimated to make up the majority of patients treated in basic 
mental healthcare, but it is important to increase our under-
standing of the cost-effectiveness of the remaining patient 
population treated in basic mental healthcare.
Fourth, our analysis is limited to the Netherlands, and 
therefore the validity of our findings is limited to the specific 
context of the Dutch system in transition.
Fifth, a healthcare perspective was adopted, in which only 
data available from the reimbursement is used to compare 
intervention costs. For example, costs made for laboratory 
tests, medication, and hospitalization are not included in the 
analysis. Although we think that such resource usage is rare 
among the less complex patient population considered, a 
broader perspective, such as taking into account all health-
care costs, or taking into account societal costs such as pro-
ductivity losses, could potentially alter our findings.
Sixth, even though the new situation seems preferable 
from a cost-effectiveness point of view, desirability should 
also be evaluated from different standpoints, such as equity, 
ethics, and sustainability (Berghmans et al. 2004; Mihalo-
poulos et al. 2011).
Conclusion
The aim of this study was to compare the costs and effects 
for patients treated in basic mental healthcare with that for 
comparable patients treated in specialized mental healthcare. 
For the group of patients that was eligible for basic mental 
healthcare, the results suggest that treatment in the basic 
mental healthcare approach (after the reform of the mental 
healthcare system) was cost-saving. Treatment in basic men-
tal healthcare showed a large significant reduction in costs, 
with similar health effects. Probabilistic uncertainty analysis 
showed that the average estimates of costs are robust, and 
that the potential loss in effect is negligible.
As the healthcare system in the Netherlands is in the 
midst of a reform, it is too early to draw conclusions on 
whether the new situation is to be preferred in terms of 
cost-effectiveness. Nevertheless, results at this stage are 
promising, showing the potential for generating similar 
effectiveness at lower costs for patients with anxiety and/
or depression.
Compliance with Ethical Standards 
Conflict of interest All authors declare that he or she has no conflict 
of interest.
Ethical Approval This article does not contain studies with human par-
ticipants or animals performed by any of the authors.
Informed Consent This article used anonymous administrative data.
Open Access This article is distributed under the terms of the Creative 
Commons Attribution 4.0 International License (http://creativecom-
mons.org/licenses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
Austin, P. C. (2011a). An introduction to propensity score methods 
for reducing the effects of confounding in observational studies. 
Multivariate Behavioral Research, 46(3), 399–424. https://doi.org
/10.1080/00273171.2011.568786.
537Administration and Policy in Mental Health and Mental Health Services Research (2018) 45:530–537 
1 3
Austin, P. C. (2011b). Optimal caliper widths for propensity-score 
matching when estimating differences in means and differences 
in proportions in observational studies. Pharmaceutical Statistics, 
10(2), 150–161. https://doi.org/10.1002/pst.433.
Barkham, M., Rees, A., Shapiro, D. A., Hardy, G. E., Stiles, W. B., & 
Reynolds, S. (1996). Dose-effect relations in time-limited psy-
chotherapy for depression. Journal of Consulting and Clinical 
Psychology, 64(5), 927–935.
Baser, O. (2006). Too much ado about propensity score models? Com-
paring methods of propensity score matching. Value in Health, 
9(6), 377–385. https://doi.org/10.1111/j.1524-4733.2006.00130.x.
Berghmans, R., Berg, M., van den Burg, M., & ter Meulen, R. (2004). 
Ethical issues of cost effectiveness analysis and guideline setting 
in mental health care. Journal of Medical Ethics, 30(2), 146–150. 
https://doi.org/10.1136/jme.2003.007047.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences 
(2nd ed.). Hillsdale, NJ: Lawrence Earlbaum Associates.
Conover, W. (1999). Practical nonparametric statistics. New York: 
Wiley.
Cuijpers, P., Huibers, M., Daniel Ebert, D., Koole, S. L., & Andersson, 
G. (2013). How much psychotherapy is needed to treat depres-
sion? A metaregression analysis. Journal of Affective Disorders, 
149(1–3), 1–13. https://doi.org/10.1016/j.jad.2013.02.030.
Davison, A. C., & Hinkley, D. V. (1997). Bootstrap methods and 
their application. Technometrics, 42(2), 216. https://doi.
org/10.2307/1271471.
de Beurs, E., Barendregt, M., de Heer, A., van Duijn, E., Goeree, B., 
Kloos, M., … Merks, A. (2015). Comparing methods to denote 
treatment outcome in clinical research and benchmarking mental 
health care. Clinical Psychology & Psychotherapy. https://doi.
org/10.1002/cpp.1954.
De Jong, K., Nugter, M. A., Polak, M. G., Wagenborg, J. E. A., Spin-
hoven, P., & Heiser, W. J. (2007). The outcome questionnaire 
(OQ-45) in a Dutch population: A cross-cultural validation. Clini-
cal Psychology and Psychotherapy, 14(4), 288–301. https://doi.
org/10.1002/cpp.529.
De Ridder, A., & De Graeve, D. (2011). Can we account for selec-
tion bias? A comparison between bare metal and drug-eluting 
stents. Value in Health, 14, 3–14. https://doi.org/10.1016/j.
jval.2010.10.014.
Hakkaart-van Roijen, L., Van der Linden, N., Bouwmans, C., Kanters, 
T., & Tan, S. S. (2015). Kostenhandleiding: Methodologie van 
kostenonderzoek en referentieprijzen voor economische evaluaties 
in de gezondheidszorg.
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., & 
Greenberg, D. (2013). Consolidated health economic evaluation 
reporting standards (CHEERS): Explanation and elaboration—
A report of the ISPOR health economic evaluations publication 
guidelines task force. Value in Health, 16, 231–250. https://doi.
org/10.1016/j.jval.2013.02.002.
KPMG. (2016). Monitor Generalistische Basis GGZ. Periode January 
2011–December 2015.
Lambert, M., Morton, J., Hatfield, D., Harmon, C., Hamilton, S., & 
Shimokawa, K. (2004). Administration and scoring manual for 
the OQ-45.2 (outcome questionniare) (3nd ed.). Wilmington, DE: 
American Professional Credentialing Services LLC.
Lange, A., & Appelo, M. (2007). Korte klachtenlijst: Handleiding. 
Houten: Bohn Stafleu van Loghum.
Mihalopoulos, C., Vos, T., Pirkis, J., & Carter, R. (2011). The economic 
analysis of prevention in mental health programs. Annual Review 
of Clinical Psychology, 7, 169–201. https://doi.org/10.1146/
annurev-clinpsy-032210-104601.
Mueller, M., & Pekarik, G. (2000). Treatment duration prediction: Cli-
ent accuracy and its relationship to dropout, outcome, and satis-
faction. Psychotherapy, 37(2), 117–123.
Nas, C., & Van Geldrdop, A. (2013). Cornerstones of mental health-
care. Science Omega Review, 2, 18–19.
Normand, S.-L. T., Landrum, M. B., Guadagnoli, E., Ayanian, J. Z., 
Ryan, T. J., Cleary, P. D., & McNeil, B. J. (2001). Validating rec-
ommendations for coronary angiography following acute myocar-
dial infarction in the elderly: A matched analysis using propensity 
scores. Journal of Clinical Epidemiology, 54(4), 387–398. https://
doi.org/10.1016/S0895-4356(00)00321-8.
Owen, J., Smith, A., & Rodolfa, E. (2009). Journal of college stu-
dent clients’ expected number of counseling sessions, treat-
ment effectiveness, and termination status: Using empiri-
cal evidence to inform session limit policies. Journal of 
College Student Psychotherapy, 23(2), 37–41. https://doi.
org/10.1080/87568220902743660.
R Core Team. (2016). R: A language and environment for statistical 
computing. Vienna, Austria: R Foundation for Statistical Comput-
ing. https://www.R-project.org/.
Ripley, B., & Canty, A. (2016). boot: Bootstrap R (S-Plus) Functions.
Schulte, D., & Eifert, G. H. (2002). What to do when manuals fail? The 
dual model of psychotherapy. Clinical Psychology: Science and 
Practice, 9(3), 312–328. https://doi.org/10.1093/clipsy/9.3.312.
Sekhon, S. (2011). Multivariate and propensity score matching soft-
ware with automated balance optimization: The matching package 
for R. Journal of Statistical Software, 42(7), 1–52. Retrieved from 
http://www.jstatsoft.org/v42/i07/.
van de Ven, J.-P., Lange, A., Schrieken, B., & Emmelkamp, P. (2000). 
Interapy: De resultaten van een gecontroleerde studie naar de 
behandeling van posttraumatische stress via internet. Dth, 20(4), 
345–361. https://doi.org/10.1007/BF03060244.
van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994). 
Costs, effects and C/E-ratios alongside. Health Economics, 3, 
309–319.
Westra, D., Wilbers, G., & Angeli, F. (2016). Stuck in the middle?. 
Health Policy, 120(4), 345–349. https://doi.org/10.1016/j.
healthpol.2016.02.014.
